T. Kjaer, S. Thiel, and G. Andersen, Toward a structure-based comprehension of the lectin pathway of complement, Molecular Immunology, vol.56, issue.4, pp.413-435, 2013.
DOI : 10.1016/j.molimm.2013.05.007

S. Degn, T. Kjaer, R. Kidmose, L. Jensen, A. Hansen et al., Complement activation by ligand-driven juxtaposition of discrete pattern recognition complexes, Proceedings of the National Academy of Sciences, vol.111, issue.37, pp.13445-50, 2014.
DOI : 10.1073/pnas.1406849111

R. Kidmose, N. Laursen, J. Dobó, T. Kjaer, S. Sirotkina et al., Structural basis for activation of the complement system by component C4 cleavage, Proceedings of the National Academy of Sciences, vol.109, issue.38, pp.15425-15455, 2012.
DOI : 10.1073/pnas.1208031109

P. Gál, V. Harmat, A. Kocsis, T. Bián, L. Barna et al., A True Autoactivating Enzyme: STRUCTURAL INSIGHT INTO MANNOSE-BINDING LECTIN-ASSOCIATED SERINE PROTEASE-2 ACTIVATIONS, Journal of Biological Chemistry, vol.280, issue.39, pp.33435-33479, 2005.
DOI : 10.1074/jbc.M506051200

T. Kinoshita, Y. Takata, H. Kozono, J. Takeda, K. Hong et al., C5 convertase of the alternative complement pathway: covalent linkage between two C3b molecules within the trimolecular complex enzyme, J Immunol, issue.141, pp.19503895-901, 1988.

D. Bubeck, The Making of a Macromolecular Machine: Assembly of the Membrane Attack Complex, Biochemistry, vol.53, issue.12, pp.1908-1923, 2014.
DOI : 10.1021/bi500157z

K. Joiner, E. Brown, C. Hammer, K. Warren, and M. Frank, Studies on the mechanism of bacterial resistance to complement-mediated killing. III. C5b-9 deposits stably on rough and type 7 S. pneumoniae without causing bacterial killing, J Immunol, vol.130, pp.845-854, 1983.

S. Bhakdi, G. Kuller, M. Muhly, S. Fromm, G. Seibert et al., Formation of transmural complement pores in serum-sensitive Escherichia coli, Infect Immun, vol.55, pp.206-216, 1987.

L. Lewis and R. S. , Meningococcal disease and the complement system, Virulence, vol.29, issue.1, pp.98-126, 2014.
DOI : 10.1128/CMR.00048-09

D. Cole and B. Morgan, Beyond lysis: how complement influences cell fate, Clinical Science, vol.104, issue.5, pp.1979455-66, 2003.
DOI : 10.1042/CS20020362

B. Morgan, Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects, Biochemical Journal, vol.264, issue.1, pp.1-14, 1989.
DOI : 10.1042/bj2640001

D. Campbell, J. Gagnon, K. Reid, and A. Williams, Rat brain Thy-1 glycoprotein. The amino acid sequence, disulphide bonds and an unusual hydrophobic region, Biochemical Journal, vol.195, issue.1, pp.15-30, 1981.
DOI : 10.1042/bj1950015

B. Morgan and A. Campbell, The recovery of human polymorphonuclear leucocytes from sublytic complement attack is mediated by changes in intracellular free calcium, Biochemical Journal, vol.231, issue.1, pp.205-213, 1985.
DOI : 10.1042/bj2310205

J. Bohnsack, O. Shea, J. Takahashi, T. Brown, and E. , Fibronectin-enhanced phagocytosis of an alternative pathway activator by human culture-derived macrophages is mediated by the C4b

F. Griffin and P. Mullinax, High concentrations of bacterial lipopolysaccharide, but not microbial infection-induced inflammation, activate macrophage C3 receptors for phagocytosis, J Immunol, issue.145, pp.1950697-701, 1990.

M. Tosi, H. Zakem, and M. Berger, Neutrophil elastase cleaves C3bi on opsonized pseudomonas as well as CR1 on neutrophils to create a functionally important opsonin receptor mismatch., Journal of Clinical Investigation, vol.86, issue.1, pp.300-308, 1990.
DOI : 10.1172/JCI114699

A. Dupuy and E. Caron, Integrin-dependent phagocytosis - spreading from microadhesion to new concepts, Journal of Cell Science, vol.121, issue.11, pp.1773-83, 2008.
DOI : 10.1242/jcs.018036

L. Uotila, M. Aatonen, and C. Gahmberg, Integrin CD11c/CD18 ??-Chain Phosphorylation Is Functionally Important, Journal of Biological Chemistry, vol.288, issue.46, pp.33494-33503, 2013.
DOI : 10.1074/jbc.C113.497446

G. Ross and V. Vetvicka, CR3 (CD11b, CD18): a phagocyte and NK cell membrane receptor with multiple ligand specificities and functions, Clinical & Experimental Immunology, vol.54, issue.2, pp.181-185, 1993.
DOI : 10.1111/j.1365-2249.1993.tb03377.x

A. Aderem and D. Underhill, MECHANISMS OF PHAGOCYTOSIS IN MACROPHAGES, Annual Review of Immunology, vol.17, issue.1, pp.593-623, 1999.
DOI : 10.1146/annurev.immunol.17.1.593

N. Gorgani, J. He, K. Katschke, K. Helmy, H. Xi et al., Complement Receptor of the Ig Superfamily Enhances Complement-Mediated Phagocytosis in a Subpopulation of Tissue Resident Macrophages, The Journal of Immunology, vol.181, issue.11, pp.7902-7910, 1950.
DOI : 10.4049/jimmunol.181.11.7902

T. Mayadas and X. Cullere, Neutrophil ??2 integrins: moderators of life or death decisions, Trends in Immunology, vol.26, issue.7, pp.388-95, 2005.
DOI : 10.1016/j.it.2005.05.002

A. Klos, A. Tenner, K. Johswich, R. Ager, E. Reis et al., The role of the anaphylatoxins in health and disease, Molecular Immunology, vol.46, issue.14, pp.2753-66, 2009.
DOI : 10.1016/j.molimm.2009.04.027

A. Klos, E. Wende, K. Wareham, and P. Monk, International Union of Pharmacology. LXXXVII. Complement Peptide C5a, C4a, and C3a Receptors, LXXXVII. Complement peptide C5a, C4a, and C3a receptors, pp.500-543, 2013.
DOI : 10.1124/pr.111.005223

Y. Murakami, T. Imamichi, and S. Nagasawa, Characterization of C3a anaphylatoxin receptor on guinea-pig macrophages, Immunology, vol.79, pp.633-641, 1993.

J. Elsner, M. Oppermann, W. Czech, G. Dobos, E. Schöpf et al., C3a activates reactive oxygen radical species production and intracellular calcium transients in human eosinophils, European Journal of Immunology, vol.49, issue.3, pp.518-540, 1994.
DOI : 10.1002/eji.1830240304

J. Elsner, M. Oppermann, W. Czech, and A. Kapp, C3a activates the respiratory burst in human polymorphonuclear neutrophilic leukocytes via pertussis toxinsensitive G-proteins, Blood, vol.83, pp.3324-3355, 1994.

T. Kretzschmar, A. Jeromin, C. Gietz, W. Bautsch, A. Klos et al., Chronic myelogenous leukemia-derived basophilic granulocytes express a functional active receptor for the anaphylatoxin C3a, European Journal of Immunology, vol.30, issue.2, pp.558-61, 1993.
DOI : 10.1002/eji.1830230239

S. El-lati, C. Dahinden, and M. Church, Complement Peptides C3a- and C5a-Induced Mediator Release from Dissociated Human Skin Mast Cells, Journal of Investigative Dermatology, vol.102, issue.5, pp.803-809, 1994.
DOI : 10.1111/1523-1747.ep12378589

L. Coulthard and T. Woodruff, Is the Complement Activation Product C3a a Proinflammatory Molecule? Re-evaluating the Evidence and the Myth, The Journal of Immunology, vol.194, issue.8
DOI : 10.4049/jimmunol.1403068

N. Chen, C. Mirtsos, D. Suh, Y. Lu, W. Lin et al., C5L2 is critical for the biological activities of the anaphylatoxins C5a and C3a, Nature, vol.162, issue.7132, pp.203-210, 2007.
DOI : 10.1038/nature05559

P. Daffern, P. Pfeifer, J. Ember, and T. Hugli, C3a is a chemotaxin for human eosinophils but not for neutrophils. I. C3a stimulation of neutrophils is secondary to eosinophil activation, Journal of Experimental Medicine, vol.181, issue.6, pp.2119-2146, 1995.
DOI : 10.1084/jem.181.6.2119

T. Hollmann, S. Mueller-ortiz, M. Braun, and R. Wetsel, Disruption of the C5a receptor gene increases resistance to acute Gram-negative bacteremia and endotoxic shock: Opposing roles of C3a and C5a, Molecular Immunology, vol.45, issue.7, pp.1907-1922, 2008.
DOI : 10.1016/j.molimm.2007.10.037

M. Wu, F. Brennan, J. Lynch, S. Mantovani, S. Phipps et al., The receptor for complement component C3a mediates protection from intestinal ischemia-reperfusion injuries by inhibiting neutrophil mobilization, Proceedings of the National Academy of Sciences, vol.110, issue.23, pp.9439-9483, 2013.
DOI : 10.1073/pnas.1218815110

T. Tsuruta, T. Yamamoto, S. Matsubara, S. Nagasawa, S. Tanase et al., Novel function of C4a anaphylatoxin. Release from monocytes of protein which inhibits monocyte chemotaxis, Am J Pathol, vol.142, pp.1848-57, 1993.

Y. Zhao, H. Xu, W. Yu, and B. Xie, Complement anaphylatoxin C4a inhibits C5a-induced neointima formation following arterial injury, Molecular Medicine Reports, vol.10, pp.45-52, 2014.
DOI : 10.3892/mmr.2014.2176

S. Barnum, C4a: An Anaphylatoxin in Name Only, Journal of Innate Immunity, vol.7, issue.4, 2015.
DOI : 10.1159/000371423

W. Campbell, E. Lazoura, N. Okada, and H. Okada, Inactivation of C3a and C5a Octapeptides by Carboxypeptidase R and Carboxypeptidase N, Microbiology and Immunology, vol.269, issue.2, pp.131-135, 2002.
DOI : 10.1111/j.1348-0421.2002.tb02669.x

K. Matthews, S. Mueller-ortiz, and R. Wetsel, Carboxypeptidase N: a pleiotropic regulator of inflammation, Molecular Immunology, vol.40, issue.11, pp.785-93, 2004.
DOI : 10.1016/j.molimm.2003.10.002

S. Mueller-ortiz, D. Wang, J. Morales, L. Li, J. Chang et al., Targeted Disruption of the Gene Encoding the Murine Small Subunit of Carboxypeptidase N (CPN1) Causes Susceptibility to C5a Anaphylatoxin-Mediated Shock, The Journal of Immunology, vol.182, issue.10, pp.19506533-19506542, 2009.
DOI : 10.4049/jimmunol.0804207

Z. Shao, T. Nishimura, L. Leung, and J. Morser, Carboxypeptidase B2 deficiency reveals opposite effects of complement C3a and C5a in a murine polymicrobial sepsis model, Journal of Thrombosis and Haemostasis, vol.16, issue.6, 2015.
DOI : 10.1111/jth.12956

S. Sayah, A. Jauneau, C. Patte, M. Tonon, H. Vaudry et al., Two different transduction pathways are activated by C3a and C5a anaphylatoxins on astrocytes, Molecular Brain Research, vol.112, issue.1-2, pp.53-60, 2003.
DOI : 10.1016/S0169-328X(03)00046-9

J. Schatz-jakobsen, L. Yatime, C. Larsen, S. Petersen, A. Klos et al., Structural and functional characterization of human and murine C5a anaphylatoxins, Acta Crystallographica Section D Biological Crystallography, vol.28, issue.6, pp.1704-1721, 2014.
DOI : 10.1107/S139900471400844X/dw5099sup1.pdf

T. Crass, U. Raffetseder, U. Martin, M. Grove, A. Klos et al., Expression cloning of the human C3a anaphylatoxin receptor (C3aR) from differentiated U-937 cells, European Journal of Immunology, vol.134, issue.8, pp.1944-50, 1996.
DOI : 10.1002/eji.1830260840

H. Wilken, O. Götze, T. Werfel, and J. Zwirner, C3a(desArg) does not bind to and signal through the human C3a receptor, Immunology Letters, vol.67, issue.2, pp.141-146, 1999.
DOI : 10.1016/S0165-2478(99)00002-4

R. Venkatesha, B. Thangam, E. Zaidi, A. Ali, and H. , Distinct regulation of C3a-induced MCP-1/CCL2 and RANTES/CCL5 production in human mast cells by extracellular signal regulated kinase and PI3 kinase, Molecular Immunology, vol.42, issue.5, pp.581-588, 2005.
DOI : 10.1016/j.molimm.2004.09.009

K. Hartmann, B. Henz, S. Krüger-krasagakes, J. Köhl, R. Burger et al., C3a and C5a stimulate chemotaxis of human mast cells, Blood, vol.89, pp.2863-70, 1997.

E. Asgari, L. Friec, G. Yamamoto, H. Perucha, E. Sacks et al., C3a modulates IL-1?? secretion in human monocytes by regulating ATP efflux and subsequent NLRP3 inflammasome activation, Blood, vol.122, issue.20, pp.3473-81, 2013.
DOI : 10.1182/blood-2013-05-502229

T. Takabayashi, E. Vannier, B. Clark, N. Margolis, C. Dinarello et al., A new biologic role for C3a and C3a desArg: regulation of TNF-alpha and IL-1 beta synthesis, J Immunol, issue.156, pp.19503455-60, 1996.

W. Fischer and T. Hugli, Regulation of B cell functions by C3a and C3a(desArg): suppression of TNF-alpha, IL-6, and the polyclonal immune response, J Immunol, issue.159, pp.19504279-86, 1997.

Q. Peng, K. Li, K. Anderson, C. Farrar, B. Lu et al., Local production and activation of complement up-regulates the allostimulatory function of dendritic cells through C3a-C3aR interaction, Blood, vol.111, issue.4, pp.2452-61, 2008.
DOI : 10.1182/blood-2007-06-095018

A. Ghannam, J. Fauquert, C. Thomas, C. Kemper, and C. Drouet, Human complement C3 deficiency: Th1 induction requires T cell-derived complement C3a and CD46 activation, Molecular Immunology, vol.58, issue.1, pp.98-107, 2014.
DOI : 10.1016/j.molimm.2013.11.010

P. Heeger and C. Kemper, Novel roles of complement in T effector cell regulation, Immunobiology, vol.217, issue.2, pp.216-240, 2012.
DOI : 10.1016/j.imbio.2011.06.004

M. Goligorsky, D. Patschan, and M. Kuo, Weibel???Palade bodies???sentinels of acute stress, Nature Reviews Nephrology, vol.96, issue.7, pp.423-429, 2009.
DOI : 10.1038/nrneph.2009.87

J. Sadler, BIOCHEMISTRY AND GENETICS OF VON WILLEBRAND FACTOR, Annual Review of Biochemistry, vol.67, issue.1, pp.395-424, 1998.
DOI : 10.1146/annurev.biochem.67.1.395

I. Del-conde, Platelet activation leads to activation and propagation of the complement system, The Journal of Experimental Medicine, vol.92, issue.6, 2005.
DOI : 10.1182/blood-2004-04-1365

M. Morigi, M. Galbusera, S. Gastoldi, M. Locatelli, S. Buelli et al., Alternative Pathway Activation of Complement by Shiga Toxin Promotes Exuberant C3a Formation That Triggers Microvascular Thrombosis, The Journal of Immunology, vol.187, issue.1, pp.172-80, 2011.
DOI : 10.4049/jimmunol.1100491

N. Gerard and C. Gerard, The chemotactic receptor for human C5a anaphylatoxin, Nature, vol.349, issue.6310, pp.614-621, 1991.
DOI : 10.1038/349614a0

M. Perianayagam, V. Balakrishnan, A. King, B. Pereira, and B. Jaber, C5a delays apoptosis of human neutrophils by a phosphatidylinositol 3-kinase-signaling pathway, Kidney International, vol.61, issue.2, pp.456-63, 2002.
DOI : 10.1046/j.1523-1755.2002.00139.x

A. La-sala, M. Gadina, and B. Kelsall, Gi-Protein-Dependent Inhibition of IL-12 Production Is Mediated by Activation of the Phosphatidylinositol 3-Kinase-Protein 3 Kinase B/Akt Pathway and JNK, The Journal of Immunology, vol.175, issue.5, pp.2994-3003, 1950.
DOI : 10.4049/jimmunol.175.5.2994

H. Jiang, Y. Kuang, Y. Wu, W. Xie, M. Simon et al., Roles of phospholipase C ??2 in chemoattractant-elicited responses, Proceedings of the National Academy of Sciences, vol.94, issue.15, pp.7971-7976, 1997.
DOI : 10.1073/pnas.94.15.7971

T. Mullmann, M. Siegel, R. Egan, and M. Billah, Complement C5a activation of phospholipase D in human neutrophils. A major route to the production of phosphatidates and diglycerides, J Immunol, issue.144, pp.19501901-19501909, 1990.

A. Buhl, N. Avdi, G. Worthen, and G. Johnson, Mapping of the C5a receptor signal transduction network in human neutrophils., Proceedings of the National Academy of Sciences, vol.91, issue.19, 1994.
DOI : 10.1073/pnas.91.19.9190

R. Aksamit, W. Falk, and E. Leonard, Chemotaxis by mouse macrophage cell lines, J Immunol, issue.126, pp.2194-2203, 1950.

M. Ehrengruber, T. Geiser, and D. Deranleau, Activation of human neutrophils by C3a and C5A. Comparison of the effects on shape changes, chemotaxis, secretion, and respiratory burst, FEBS Lett, vol.34694, pp.181-185, 1994.

M. Lett-brown and E. Leonard, Histamine-induced inhibition of normal human basophil chemotaxis to C5a, J Immunol, issue.118, pp.1950815-1950823, 1977.

M. Markiewski, R. Deangelis, F. Benencia, S. Ricklin-lichtsteiner, A. Koutoulaki et al., Modulation of the antitumor immune response by complement, Nature Immunology, vol.198, issue.11, pp.1225-1260, 2008.
DOI : 10.1038/ni.1655

S. Nataf, N. Davoust, R. Ames, and S. Barnum, Human T cells express the C5a receptor and are chemoattracted to C5a, J Immunol, issue.162, pp.19504018-19504041, 1999.

L. Ottonello, A. Corcione, G. Tortolina, I. Airoldi, E. Albesiano et al., rC5a directs the in vitro migration of human memory and naive tonsillar B lymphocytes: implications for B cell trafficking in secondary lymphoid tissues, J Immunol, issue.162, pp.19506510-19506517, 1999.

P. Lalli, M. Strainic, F. Lin, M. Medof, and P. Heeger, Decay accelerating factor can control T cell differentiation into IFN-gamma-producing effector cells via regulating local C5a-induced IL-12 production, J Immunol, issue.179, pp.5793-802, 1950.

B. Czermak, V. Sarma, C. Pierson, R. Warner, M. Huber-lang et al., Protective effects of C5a blockade in sepsis, Nat Med, vol.5, pp.788-92, 1999.

D. Cortright, R. Meade, S. Waters, B. Chenard, and J. Krause, C5a, But Not C3a, Increases VEGF Secretion in ARPE-19 Human Retinal Pigment Epithelial Cells, Current Eye Research, vol.152, issue.1, pp.57-61, 2009.
DOI : 10.1021/bi034489v

U. Jain, Q. Cao, N. Thomas, T. Woodruff, W. Schwaeble et al., Properdin provides protection from Citrobacter rodentium-induced intestinal inflammation in a C5a/IL-6-dependent manner, J Immunol, pp.3414-3435, 0194.

W. Cui, M. Lapointe, D. Gauvreau, D. Kalant, and K. Cianflone, Recombinant C3adesArg/acylation stimulating protein (ASP) is highly bioactive: A critical evaluation of C5L2 binding and 3T3-L1 adipocyte activation, Molecular Immunology, vol.46, issue.16, pp.3207-3224, 2009.
DOI : 10.1016/j.molimm.2009.08.013

S. Cain and P. Monk, The Orphan Receptor C5L2 Has High Affinity Binding Sites for Complement Fragments C5a and C5a des-Arg74, Journal of Biological Chemistry, vol.277, issue.9, pp.7165-7174, 2002.
DOI : 10.1074/jbc.C100714200

C. Bamberg, C. Mackay, H. Lee, D. Zahra, J. Jackson et al., The C5a Receptor (C5aR) C5L2 Is a Modulator of C5aR-mediated Signal Transduction, Journal of Biological Chemistry, vol.285, issue.10, pp.7633-7677, 2010.
DOI : 10.1074/jbc.M109.092106

R. Wang, B. Lu, C. Gerard, and N. Gerard, Disruption of the Complement Anaphylatoxin Receptor C5L2 Exacerbates Inflammation in Allergic Contact Dermatitis, The Journal of Immunology, vol.191, issue.8, pp.19504001-19504010, 0191.
DOI : 10.4049/jimmunol.1301626

N. Gerard, B. Lu, P. Liu, S. Craig, Y. Fujiwara et al., An Anti-inflammatory Function for the Complement Anaphylatoxin C5a-binding Protein, C5L2, Journal of Biological Chemistry, vol.280, issue.48, pp.39677-80, 2005.
DOI : 10.1074/jbc.C500287200

S. Vijayan, Y. Asare, J. Grommes, O. Soehnlein, E. Lutgens et al., High Expression of C5L2 Correlates with High Proinflammatory Cytokine Expression in Advanced Human Atherosclerotic Plaques, The American Journal of Pathology, vol.184, issue.7, pp.2123-2156, 2014.
DOI : 10.1016/j.ajpath.2014.04.004

P. Poursharifi, M. Lapointe, D. Pétrin, D. Devost, D. Gauvreau et al., C5L2 and C5aR interaction in adipocytes and macrophages: Insights into adipoimmunology, Cellular Signalling, vol.25, issue.4, 2013.
DOI : 10.1016/j.cellsig.2012.12.010

W. Hsu, F. Yang, C. Lin, S. Hsieh, and N. Chen, C5L2 is required for C5a-triggered receptor internalization and ERK signaling, Cellular Signalling, vol.26, issue.7, pp.1409-1428, 2014.
DOI : 10.1016/j.cellsig.2014.02.021

K. Defea, J. Zalevsky, M. Thoma, O. Déry, R. Mullins et al., ??-Arrestin???Dependent Endocytosis of Proteinase-Activated Receptor 2 Is Required for Intracellular Targeting of Activated Erk1/2, The Journal of Cell Biology, vol.29, issue.6, pp.1267-81, 2000.
DOI : 10.1074/jbc.274.30.20989

S. Dewire, S. Ahn, R. Lefkowitz, and S. Shenoy, ??-Arrestins and Cell Signaling, Annual Review of Physiology, vol.69, issue.1, pp.483-510, 2007.
DOI : 10.1146/annurev.physiol.69.022405.154749

X. Zhang, Y. Kimura, C. Fang, L. Zhou, G. Sfyroera et al., Regulation of Toll-like receptor-mediated inflammatory response by complement in vivo, Blood, vol.110, issue.1, pp.228-264, 2007.
DOI : 10.1182/blood-2006-12-063636

E. Harokopakis, M. Albzreh, M. Martin, and G. Hajishengallis, TLR2 Transmodulates Monocyte Adhesion and Transmigration via Rac1- and PI3K-Mediated Inside-Out Signaling in Response to Porphyromonas gingivalis Fimbriae, The Journal of Immunology, vol.176, issue.12
DOI : 10.4049/jimmunol.176.12.7645

J. Kagan and R. Medzhitov, Phosphoinositide-Mediated Adaptor Recruitment Controls Toll-like Receptor Signaling, Cell, vol.125, issue.5, pp.943-55, 2006.
DOI : 10.1016/j.cell.2006.03.047

M. Koleva, G. Schlaf, R. Landmann, O. Götze, K. Jungermann et al., Induction of anaphylatoxin C5a receptors in rat hepatocytes by lipopolysaccharide in vivo: Mediation by interleukin-6 from Kupffer cells, Gastroenterology, vol.122, issue.3, pp.697-70831883, 2002.
DOI : 10.1053/gast.2002.31883

H. Hawlisch, Y. Belkaid, R. Baelder, D. Hildeman, C. Gerard et al., C5a Negatively Regulates Toll-like Receptor 4-Induced Immune Responses, Immunity, vol.22, issue.4, pp.415-441, 2005.
DOI : 10.1016/j.immuni.2005.02.006
URL : http://doi.org/10.1016/j.immuni.2005.02.006

F. Rudilla, C. Fayolle, N. Casares, M. Durantez, L. Arribillaga et al., Combination of a TLR4 ligand and anaphylatoxin C5a for the induction of antigen-specific cytotoxic T cell responses, Vaccine, vol.30, issue.18, pp.2848-58, 2012.
DOI : 10.1016/j.vaccine.2012.02.052

A. Zaal, S. Lissenberg-thunnissen, G. Van-schijndel, D. Wouters, S. Van-ham et al., Crosstalk between Toll like receptors and C5a receptor in human monocyte derived DCs suppress inflammatory cytokine production, Immunobiology, vol.218, issue.2, pp.175-80, 2013.
DOI : 10.1016/j.imbio.2012.02.014

M. Pepys, ROLE OF COMPLEMENT IN INDUCTION OF ANTIBODY PRODUCTION IN VIVO: EFFECT OF COBRA FACTOR AND OTHER C3-REACTIVE AGENTS ON THYMUS-DEPENDENT AND THYMUS-INDEPENDENT ANTIBODY RESPONSES, Journal of Experimental Medicine, vol.140, issue.1, pp.126-171, 1974.
DOI : 10.1084/jem.140.1.126

M. Pepys and A. Butterworth, Inhibition by C3 fragments of C3-dependent rosette formation and antigen-induced lymphocyte transformation, Clin Exp Immunol, vol.18, pp.273-82, 1974.

A. Matsumoto, D. Martin, R. Carter, L. Klickstein, J. Ahearn et al., Functional dissection of the CD21/CD19/TAPA-1/Leu-13 complex of B lymphocytes, Journal of Experimental Medicine, vol.178, issue.4, pp.1407-1424, 1993.
DOI : 10.1084/jem.178.4.1407

A. Cherukuri, P. Cheng, and S. Pierce, The Role of the CD19/CD21 Complex in B Cell Processing and Presentation of Complement-Tagged Antigens, The Journal of Immunology, vol.167, issue.1, pp.1950163-72, 2001.
DOI : 10.4049/jimmunol.167.1.163

G. Klaus and J. Humphrey, A re-evaluation of the role of C3 in B-cell activation, Immunology Today, vol.7, issue.6, pp.163-168, 1986.
DOI : 10.1016/0167-5699(86)90165-9

Y. Fang, C. Xu, Y. Fu, V. Holers, and H. Molina, Expression of complement receptors 1 and 2 on follicular dendritic cells is necessary for the generation of a strong antigen-specific IgG response, J Immunol, vol.160, pp.5273-5282, 1998.

P. Dempsey, M. Allison, S. Akkaraju, C. Goodnow, and D. Fearon, C3d of Complement as a Molecular Adjuvant: Bridging Innate and Acquired Immunity, Science, vol.271, issue.5247, 1996.
DOI : 10.1126/science.271.5247.348

S. Brodeur, F. Angelini, L. Bacharier, A. Blom, E. Mizoguchi et al., C4b-Binding Protein (C4BP) Activates B Cells through the CD40 Receptor, Immunity, vol.18, issue.6, pp.837-885, 2003.
DOI : 10.1016/S1074-7613(03)00149-3

P. Chatterjee, A. Agyemang, M. Alimzhanov, S. Degn, S. Tsiftsoglou et al., Complement C4 maintains peripheral B-cell tolerance in a myeloid cell dependent manner, European Journal of Immunology, vol.30, issue.9, pp.2441-50, 2013.
DOI : 10.1002/eji.201343412

D. Nagro, C. Kolla, R. Rickert, and R. , A Critical Role for Complement C3d and the B Cell Coreceptor (CD19/CD21) Complex in the Initiation of Inflammatory Arthritis, The Journal of Immunology, vol.175, issue.8, pp.5379-89, 2005.
DOI : 10.4049/jimmunol.175.8.5379

T. Lyubchenko, D. Porto, J. Holers, V. Cambier, and J. , Cutting Edge: Complement (C3d)-Linked Antigens Break B Cell Anergy, The Journal of Immunology, vol.179, issue.5, pp.19502695-19502704, 2007.
DOI : 10.4049/jimmunol.179.5.2695

L. Hundgeburth, M. Wunsch, D. Rovituso, M. Recks, K. Addicks et al., The complement system contributes to the pathology of experimental autoimmune encephalomyelitis by triggering demyelination and modifying the antigen-specific T and B cell response, Clinical Immunology, vol.146, issue.3, pp.155-64, 2013.
DOI : 10.1016/j.clim.2012.12.007

C. Kemper and J. Atkinson, T-cell regulation: with complements from innate immunity, Nature Reviews Immunology, vol.50, issue.1, pp.9-18, 1994.
DOI : 10.1038/nri1994

C. Kemper, A. Chan, J. Green, K. Brett, K. Murphy et al., Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype, Nature, vol.274, issue.6921, pp.388-92, 2003.
DOI : 10.1038/nature01315

B. Morgan, K. Marchbank, M. Longhi, C. Harris, and A. Gallimore, Complement: central to innate immunity and bridging to adaptive responses, Immunology Letters, vol.97, issue.2, 2005.
DOI : 10.1016/j.imlet.2004.11.010

L. Baudino, A. Sardini, M. Ruseva, L. Fossati-jimack, H. Cook et al., C3 opsonization regulates endocytic handling of apoptotic cells resulting in enhanced T-cell responses to cargo-derived antigens, Proceedings of the National Academy of Sciences, vol.111, issue.4, pp.1503-1511, 2014.
DOI : 10.1073/pnas.1316877111

S. Mueller-ortiz, J. Morales, and R. Wetsel, The Receptor for the Complement C3a Anaphylatoxin (C3aR) Provides Host Protection against Listeria monocytogenes-Induced Apoptosis, The Journal of Immunology, vol.193, issue.3, pp.1278-89, 2014.
DOI : 10.4049/jimmunol.1302787

W. Kwan, W. Van-der-touw, E. Paz-artal, M. Li, and P. Heeger, Signaling through C5a receptor and C3a receptor diminishes function of murine natural regulatory T cells, The Journal of Experimental Medicine, vol.32, issue.2, pp.257-68, 2013.
DOI : 10.1038/ni.1774

M. Strainic, E. Shevach, F. An, F. Lin, and M. Medof, Absence of signaling into CD4+ cells via C3aR and C5aR enables autoinductive TGF-??1 signaling and induction of Foxp3+ regulatory T cells, Nature Immunology, vol.19, issue.2, pp.162-71, 2013.
DOI : 10.1084/jem.20041967

L. Friec, G. Sheppard, D. Whiteman, P. Karsten, C. Shamoun et al., The CD46-Jagged1 interaction is critical for human TH1 immunity, Nature Immunology, vol.164, issue.12, pp.1213-1234, 2012.
DOI : 10.1021/ja00105a005

A. Ghannam, M. Pernollet, J. Fauquert, N. Monnier, D. Ponard et al., Human C3 Deficiency Associated with Impairments in Dendritic Cell Differentiation, Memory B Cells, and Regulatory T Cells, The Journal of Immunology, vol.181, issue.7, pp.5158-66, 1950.
DOI : 10.4049/jimmunol.181.7.5158
URL : https://hal.archives-ouvertes.fr/inserm-00381929

M. Kolev, L. Friec, G. Kemper, and C. , The role of complement in CD4+ T cell homeostasis and effector functions, Seminars in Immunology, vol.25, issue.1, pp.12-21, 2013.
DOI : 10.1016/j.smim.2013.04.012

J. Cardone, L. Friec, G. Vantourout, P. Roberts, A. Fuchs et al., Complement regulator CD46 temporally regulates cytokine production by conventional and unconventional T cells, Nature Immunology, vol.163, issue.9, pp.862-71, 1917.
DOI : 10.1110/ps.03455604
URL : https://hal.archives-ouvertes.fr/hal-00564091

P. Heeger, P. Lalli, F. Lin, A. Valujskikh, J. Liu et al., Decay-accelerating factor modulates induction of T cell immunity, The Journal of Experimental Medicine, vol.69, issue.10, pp.1523-1553, 2005.
DOI : 10.4049/jimmunol.172.1.240

J. Liu, T. Miwa, B. Hilliard, Y. Chen, J. Lambris et al., The complement inhibitory protein DAF (CD55) suppresses T cell immunity in vivo, The Journal of Experimental Medicine, vol.100, issue.4, pp.567-77, 2005.
DOI : 10.4049/jimmunol.173.4.2227

J. Dunkelberger and W. Song, Complement and its role in innate and adaptive immune responses, Cell Research, vol.71, issue.1, 2009.
DOI : 10.1146/annurev.immunol.15.1.649

A. Lipp, K. Juhasz, C. Paar, C. Ogris, P. Eckerstorfer et al., Lck Mediates Signal Transmission from CD59 to the TCR/CD3 Pathway in Jurkat T Cells, PLoS ONE, vol.285, issue.1, 2014.
DOI : 10.1371/journal.pone.0085934.s005

C. Wagner, C. Ochmann, M. Schoels, T. Giese, S. Stegmaier et al., The complement receptor 1, CR1 (CD35), mediates inhibitory signals in human T-lymphocytes, Molecular Immunology, vol.43, issue.6, pp.643-51, 2006.
DOI : 10.1016/j.molimm.2005.04.006

J. Tam, S. Bidgood, W. Mcewan, and L. James, Intracellular sensing of complement C3 activates cell autonomous immunity, Science, vol.345, issue.6201, 2014.
DOI : 10.1126/science.1256070

J. Lambris, D. Ricklin, and B. Geisbrecht, Complement evasion by human pathogens, Nature Reviews Microbiology, vol.28, issue.2, pp.132-174, 2008.
DOI : 10.1038/nrmicro1824

P. Zipfel, R. Würzner, and C. Skerka, Complement evasion of pathogens: Common strategies are shared by diverse organisms, Molecular Immunology, vol.44, issue.16, pp.3850-3857, 2007.
DOI : 10.1016/j.molimm.2007.06.149

M. Schneider, R. Exley, H. Chan, I. Feavers, Y. Kang et al., Functional Significance of Factor H Binding to Neisseria meningitidis, The Journal of Immunology, vol.176, issue.12, pp.7566-75, 2006.
DOI : 10.4049/jimmunol.176.12.7566

K. Berggård, E. Johnsson, F. Mooi, and G. Lindahl, Bordetella pertussis binds the human complement regulator C4BP: role of filamentous hemagglutinin, Infect Immun, vol.65, pp.3638-3681, 1997.

D. Ho, M. Skurnik, A. Blom, and S. Meri, Ail recruitment of C4b-binding protein leads to factor I-mediated inactivation of covalently and noncovalently bound C4b, European Journal of Immunology, vol.208, issue.3, pp.742-51, 2014.
DOI : 10.1002/eji.201343552

L. Lewis, J. Ngampasutadol, R. Wallace, J. Reid, U. Vogel et al., The meningococcal vaccine candidate Neisserial surface protein A (NspA) binds to Factor H and enhances meningococcal resistance to complement, Molecular Immunology, vol.47, issue.13, 2010.
DOI : 10.1016/j.molimm.2010.05.139

D. Ermert, A. Weckel, V. Agarwal, I. Frick, L. Björck et al., Binding of Complement Inhibitor C4b-binding Protein to a Highly Virulent Streptococcus pyogenes M1 Strain Is Mediated by Protein H and Enhances Adhesion to and Invasion of Endothelial Cells, Journal of Biological Chemistry, vol.288, issue.45, pp.32172-83, 2013.
DOI : 10.1074/jbc.M113.502955

A. Bhattacharjee, J. Oeemig, R. Kolodziejczyk, T. Meri, T. Kajander et al., Structural Basis for Complement Evasion by Lyme Disease Pathogen Borrelia burgdorferi, Journal of Biological Chemistry, vol.288, issue.26, pp.18685-95, 2013.
DOI : 10.1074/jbc.M113.459040

T. Meri, H. Amdahl, M. Lehtinen, S. Hyvärinen, J. Mcdowell et al., Microbes bind complement inhibitor factor H via a common site, PLoS Pathog, 2013.

J. Ngampasutadol, S. Ram, S. Gulati, S. Agarwal, C. Li et al., Human factor H interacts selectively with Neisseria gonorrhoeae and results in speciesspecific complement evasion, J Immunol, issue.180, pp.19503426-19503461, 2008.

M. Schneider, B. Prosser, J. Caesar, E. Kugelberg, S. Li et al., Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates, Nature, vol.35, issue.7240, pp.890-893, 2009.
DOI : 10.1038/nature07769

T. Foster, Immune evasion by staphylococci, Nature Reviews Microbiology, vol.2, issue.12, pp.948-58, 2005.
DOI : 10.1038/nrmicro1289

P. Hair, C. Foley, N. Krishna, J. Nyalwidhe, J. Geoghegan et al., Complement regulator C4BP binds to Staphylococcus aureus surface proteins SdrE and Bbp inhibiting bacterial opsonization and killing, Results in Immunology, vol.3, pp.114-135, 2013.
DOI : 10.1016/j.rinim.2013.10.004

J. Sharp, C. Echague, P. Hair, M. Ward, J. Nyalwidhe et al., Staphylococcus aureus Surface Protein SdrE Binds Complement Regulator Factor H as an Immune Evasion Tactic, PLoS ONE, vol.4, issue.5, 2012.
DOI : 10.1371/journal.pone.0038407.t002

M. Liszewski, M. Leung, R. Hauhart, R. Buller, P. Bertram et al., Structure and Regulatory Profile of the Monkeypox Inhibitor of Complement: Comparison to Homologs in Vaccinia and Variola and Evidence for Dimer Formation, The Journal of Immunology, vol.176, issue.6, pp.3725-3759, 2006.
DOI : 10.4049/jimmunol.176.6.3725

J. Lubinski, L. Wang, A. Soulika, R. Burger, R. Wetsel et al., Herpes simplex virus type 1 glycoprotein gC mediates immune evasion in vivo, J Virol, vol.72, pp.8257-63, 1998.

S. Rooijakkers and J. Van-strijp, Bacterial complement evasion, Molecular Immunology, vol.44, issue.1-3, pp.23-32, 2007.
DOI : 10.1016/j.molimm.2006.06.011

T. Fraga, D. Courrol, M. Castiblanco-valencia, I. Hirata, S. Vasconcellos et al., Immune Evasion by Pathogenic Leptospira Strains: The Secretion of Proteases that Directly Cleave Complement Proteins, Journal of Infectious Diseases, vol.209, issue.6, pp.876-86, 2014.
DOI : 10.1093/infdis/jit569

S. Rooijakkers, W. Van-wamel, M. Ruyken, K. Van-kessel, and J. Van-strijp, Anti-opsonic properties of staphylokinase, Microbes and Infection, vol.7, issue.3, pp.476-84, 2005.
DOI : 10.1016/j.micinf.2004.12.014

M. Jusko, J. Potempa, T. Kantyka, E. Bielecka, H. Miller et al., Staphylococcal Proteases Aid in Evasion of the Human Complement System, Journal of Innate Immunity, vol.6, issue.1, pp.31-46, 2014.
DOI : 10.1159/000351458

A. Laarman, M. Ruyken, C. Malone, J. Van-strijp, A. Horswill et al., Staphylococcus aureus Metalloprotease Aureolysin Cleaves Complement C3 To Mediate Immune Evasion, The Journal of Immunology, vol.186, issue.11, pp.6445-53, 1950.
DOI : 10.4049/jimmunol.1002948

D. Tordello, E. Vacca, I. Ram, S. Rappuoli, R. Serruto et al., Neisseria meningitidis NalP cleaves human complement C3, facilitating degradation of C3b and survival in human serum, Proceedings of the National Academy of Sciences, vol.111, issue.1, pp.427-459, 2014.
DOI : 10.1073/pnas.1321556111

S. Agarwal, S. Vasudhev, R. Deoliveira, and R. S. , Inhibition of the Classical Pathway of Complement by Meningococcal Capsular Polysaccharides, The Journal of Immunology, vol.193, issue.4, pp.1855-63, 2014.
DOI : 10.4049/jimmunol.1303177

J. Johnson, V. Borisevich, B. Rockx, and G. Parks, ABSTRACT, Journal of Virology, vol.89, issue.2, pp.989-98, 2015.
DOI : 10.1128/JVI.02427-14
URL : https://hal.archives-ouvertes.fr/hal-01336771

M. Hammel, G. Sfyroera, D. Ricklin, P. Magotti, J. Lambris et al., A structural basis for complement inhibition by Staphylococcus aureus, Nature Immunology, vol.174, issue.4, pp.430-437, 1450.
DOI : 10.1021/bi00121a029

N. Haspel, D. Ricklin, B. Geisbrecht, L. Kavraki, and J. Lambris, protein Efb-C and its complement target C3d, Protein Science, vol.31, issue.11, pp.1894-906, 2008.
DOI : 10.1110/ps.036624.108

T. Koch, M. Reuter, D. Barthel, S. Böhm, J. Van-den-elsen et al., Staphylococcus aureus Proteins Sbi and Efb Recruit Human Plasmin to Degrade Complement C3 and C3b, PLoS ONE, vol.7, issue.10, 2012.
DOI : 10.1371/journal.pone.0047638.g007

L. Lee, X. Liang, M. Hook, and E. Brown, Identification and Characterization of the C3 Binding Domain of the Staphylococcus aureus Extracellular Fibrinogen-binding Protein (Efb), Journal of Biological Chemistry, vol.279, issue.49, pp.50710-50716, 2004.
DOI : 10.1074/jbc.M408570200

L. Lee, M. Höök, D. Haviland, R. Wetsel, E. Yonter et al., Protein, The Journal of Infectious Diseases, vol.190, issue.3, pp.571-580, 2004.
DOI : 10.1086/422259
URL : https://hal.archives-ouvertes.fr/hal-00905794

M. Hammel, G. Sfyroera, S. Pyrpassopoulos, D. Ricklin, K. Ramyar et al., Characterization of Ehp, a Secreted Complement Inhibitory Protein from Staphylococcus aureus, Journal of Biological Chemistry, vol.282, issue.41, pp.30051-61, 2007.
DOI : 10.1074/jbc.M704247200

K. Haupt, M. Reuter, J. Van-den-elsen, J. Burman, S. Hälbich et al., The Staphylococcus aureus Protein Sbi Acts as a Complement Inhibitor and Forms a Tripartite Complex with Host Complement Factor H and C3b, PLoS Pathogens, vol.275, issue.12, 2008.
DOI : 10.1371/journal.ppat.1000250.s003

A. Upadhyay, J. Burman, E. Clark, E. Leung, D. Isenman et al., Immune Subversion Protein Sbi, Journal of Biological Chemistry, vol.283, issue.32, pp.22113-22133, 2008.
DOI : 10.1074/jbc.M802636200

I. Jongerius, J. Köhl, M. Pandey, M. Ruyken, K. Van-kessel et al., Staphylococcal complement evasion by various convertase-blocking molecules, The Journal of Experimental Medicine, vol.142, issue.10, pp.2461-71, 2007.
DOI : 10.1023/A:1027315814817

B. Garcia, K. Ramyar, A. Tzekou, D. Ricklin, W. Mcwhorter et al., Molecular Basis for Complement Recognition and Inhibition Determined by Crystallographic Studies of the Staphylococcal Complement Inhibitor (SCIN) Bound to C3c and C3b, Journal of Molecular Biology, vol.402, issue.1, pp.17-29, 2010.
DOI : 10.1016/j.jmb.2010.07.029

B. Garcia, K. Ramyar, D. Ricklin, J. Lambris, and B. Geisbrecht, Advances in Understanding the Structure, Function, and Mechanism of the SCIN and Efb Families of Staphylococcal Immune Evasion Proteins, Adv Exp Med Biol, vol.946, pp.113-146, 2012.
DOI : 10.1007/978-1-4614-0106-3_7

D. Ricklin, A. Tzekou, B. Garcia, M. Hammel, W. Mcwhorter et al., A Molecular Insight into Complement Evasion by the Staphylococcal Complement Inhibitor Protein Family, The Journal of Immunology, vol.183, issue.4, pp.2565-74, 1950.
DOI : 10.4049/jimmunol.0901443

S. Rooijakkers, J. Wu, M. Ruyken, R. Van-domselaar, K. Planken et al., Structural and functional implications of the alternative complement pathway C3 convertase stabilized by a staphylococcal inhibitor, Nature Immunology, vol.23, issue.7, pp.721-728, 2009.
DOI : 10.1038/ni.1756

I. Jongerius, M. Puister, J. Wu, M. Ruyken, J. Van-strijp et al., Staphylococcal Complement Inhibitor Modulates Phagocyte Responses by Dimerization of Convertases, The Journal of Immunology, vol.184, issue.1, pp.1950420-1950425, 2010.
DOI : 10.4049/jimmunol.0902865

D. Ricklin and J. Lambris, Compstatin: A Complement Inhibitor on its Way to Clinical Application, Adv Exp Med Biol, vol.632, pp.273-92, 2008.
DOI : 10.1007/978-0-387-78952-1_20

D. Serruto, R. Rappuoli, M. Scarselli, P. Gros, and J. Van-strijp, Molecular mechanisms of complement evasion: learning from staphylococci and meningococci, Nature Reviews Microbiology, vol.25, issue.6, pp.393-402, 2010.
DOI : 10.1038/nrmicro2366

J. Leffler, A. Bengtsson, and A. Blom, The complement system in systemic lupus erythematosus: an update, Annals of the Rheumatic Diseases, vol.632, issue.9, pp.1601-1607, 2014.
DOI : 10.1136/annrheumdis-2014-205287

L. Schejbel, L. Skattum, S. Hagelberg, A. Åhlin, B. Schiller et al., Molecular basis of hereditary C1q deficiency???revisited: identification of several novel disease-causing mutations, Genes and Immunity, vol.168, issue.8, pp.626-3439, 2011.
DOI : 10.1196/annals.1422.021

Y. Yin, X. Wu, G. Shan, and X. Zhang, Diagnostic value of serum anti-C1q antibodies in patients with lupus nephritis: a meta-analysis, Lupus, vol.21, issue.10, pp.1088-97, 2012.
DOI : 10.1186/1471-2288-11-41

D. Vanhecke, L. Roumenina, H. Wan, M. Osthoff, M. Schaller et al., Identification of a major linear C1q epitope allows detection of systemic lupus erythematosus anti-C1q antibodies by a specific peptide-based enzyme-linked immunosorbent assay, Arthritis & Rheumatism, vol.43, issue.11, pp.3706-3720, 2012.
DOI : 10.1002/art.34605

M. Mahler, R. Van-schaarenburg, and L. Trouw, Anti-C1q Autoantibodies, Novel Tests, and Clinical Consequences, Frontiers in Immunology, vol.4, 2013.
DOI : 10.3389/fimmu.2013.00117

L. Trouw, T. Groeneveld, M. Seelen, J. Duijs, I. Bajema et al., Anti-C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune complexes, Journal of Clinical Investigation, vol.114, issue.5, pp.679-8810, 1172.
DOI : 10.1172/JCI200421075

C. Bigler, M. Schaller, I. Perahud, M. Osthoff, and M. Trendelenburg, Autoantibodies against complement C1q specifically target C1q bound on early apoptotic cells, J Immunol, issue.183, pp.19503512-19503533, 2009.

M. Noris and G. Remuzzi, Atypical Hemolytic???Uremic Syndrome, New England Journal of Medicine, vol.361, issue.17, pp.1676-87, 2009.
DOI : 10.1056/NEJMra0902814

L. Roumenina, C. Loirat, M. Dragon-durey, L. Halbwachs-mecarelli, C. Sautes-fridman et al., Alternative complement pathway assessment in patients with atypical HUS, Journal of Immunological Methods, vol.365, issue.1-2, pp.8-26, 2011.
DOI : 10.1016/j.jim.2010.12.020

F. Fakhouri, V. Frémeaux-bacchi, L. Noël, H. Cook, and M. Pickering, C3 glomerulopathy: a new classification, Nature Reviews Nephrology, vol.118, issue.8, pp.494-503, 2010.
DOI : 10.1038/nrd3011

S. Sethi and F. Fervenza, Membranoproliferative Glomerulonephritis ??? A New Look at an Old Entity, New England Journal of Medicine, vol.366, issue.12, pp.1119-1150, 2012.
DOI : 10.1056/NEJMra1108178

M. Malina, L. Roumenina, T. Seeman, L. Quintrec, M. Dragon-durey et al., Genetics of hemolytic uremic syndromes, Presse Méd, pp.105-119, 2012.
DOI : 10.1016/j.lpm.2011.10.028

V. Ferreira, A. Herbert, C. Cortés, K. Mckee, B. Blaum et al., The Binding of Factor H to a Complex of Physiological Polyanions and C3b on Cells Is Impaired in Atypical Hemolytic Uremic Syndrome, The Journal of Immunology, vol.182, issue.11, pp.7009-7027, 1950.
DOI : 10.4049/jimmunol.0804031

M. Lehtinen, A. Rops, D. Isenman, J. Van-der-vlag, and T. Jokiranta, Mutations of Factor H Impair Regulation of Surface-bound C3b by Three Mechanisms in Atypical Hemolytic Uremic Syndrome, Journal of Biological Chemistry, vol.284, issue.23, pp.15650-15658, 2009.
DOI : 10.1074/jbc.M900814200

T. Manuelian, J. Hellwage, S. Meri, J. Caprioli, M. Noris et al., Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome, Journal of Clinical Investigation, vol.111, issue.8, pp.1181-9010, 1172.
DOI : 10.1172/JCI16651

F. Bienaime, M. Dragon-durey, C. Regnier, S. Nilsson, W. Kwan et al., Mutations in components of complement influence the outcome of Factor I-associated atypical hemolytic uremic syndrome, Kidney International, vol.77, issue.4, pp.339-49472, 2009.
DOI : 10.1038/ki.2009.472

S. Nilsson, N. Kalchishkova, L. Trouw, V. Fremeaux-bacchi, B. Villoutreix et al., Mutations in complement factor I as found in atypical hemolytic uremic syndrome lead to either altered secretion or altered function of factor I, European Journal of Immunology, vol.51, issue.78, pp.172-85, 2010.
DOI : 10.1002/eji.200939280

V. Frémeaux-bacchi, E. Miller, M. Liszewski, L. Strain, J. Blouin et al., Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome, Blood, vol.112, issue.13, pp.4948-52, 2008.
DOI : 10.1182/blood-2008-01-133702

E. Goicoechea-de-jorge, C. Harris, J. Esparza-gordillo, L. Carreras, and E. Arranz, Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome, Proceedings of the National Academy of Sciences, vol.104, issue.1, pp.240-245, 2007.
DOI : 10.1073/pnas.0603420103

M. Marinozzi, L. Vergoz, T. Rybkine, S. Ngo, S. Bettoni et al., Complement Factor B Mutations in Atypical Hemolytic Uremic Syndrome--Disease-Relevant or Benign?, Journal of the American Society of Nephrology, vol.25, issue.9, pp.2053-65, 2014.
DOI : 10.1681/ASN.2013070796

L. Roumenina, M. Jablonski, C. Hue, J. Blouin, J. Dimitrov et al., Hyperfunctional C3 convertase leads to complement deposition on endothelial cells and contributes to atypical hemolytic uremic syndrome, Blood, vol.114, issue.13, pp.2837-2882, 2009.
DOI : 10.1182/blood-2009-01-197640

L. Roumenina, M. Frimat, E. Miller, F. Provot, M. Dragon-durey et al., A prevalent C3 mutation in aHUS patients causes a direct C3 convertase gain of function, Blood, vol.119, issue.18, pp.4182-91, 2012.
DOI : 10.1182/blood-2011-10-383281

E. Schramm, L. Roumenina, T. Rybkine, S. Chauvet, P. Vieira-martins et al., Mapping interactions between complement C3 and regulators using mutations in atypical hemolytic uremic syndrome, Blood, vol.125, issue.15, pp.2359-69, 2015.
DOI : 10.1182/blood-2014-10-609073

M. Dragon-durey, C. Loirat, S. Cloarec, M. Macher, J. Blouin et al., Anti-Factor H Autoantibodies Associated with Atypical Hemolytic Uremic Syndrome, Journal of the American Society of Nephrology, vol.16, issue.2, pp.555-63, 2005.
DOI : 10.1681/ASN.2004050380

M. Dragon-durey, S. Sethi, A. Bagga, C. Blanc, J. Blouin et al., Clinical Features of Anti-Factor H Autoantibody-Associated Hemolytic Uremic Syndrome, Journal of the American Society of Nephrology, vol.21, issue.12, pp.2180-2187, 2010.
DOI : 10.1681/ASN.2010030315

M. Józsi, C. Licht, S. Strobel, S. Zipfel, H. Richter et al., Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency, Blood, vol.111, issue.3, pp.1512-1516, 2008.
DOI : 10.1182/blood-2007-09-109876

C. Blanc, L. Roumenina, Y. Ashraf, S. Hyvärinen, S. Sethi et al., Overall Neutralization of Complement Factor H by Autoantibodies in the Acute Phase of the Autoimmune Form of Atypical Hemolytic Uremic Syndrome, The Journal of Immunology, vol.189, issue.7, pp.3528-3565, 1950.
DOI : 10.4049/jimmunol.1200679

V. Fremeaux-bacchi, F. Fakhouri, A. Garnier, F. Bienaimé, M. Dragon-durey et al., Genetics and Outcome of Atypical Hemolytic Uremic Syndrome: A Nationwide French Series Comparing Children and Adults, Clinical Journal of the American Society of Nephrology, vol.8, issue.4, pp.554-62, 2013.
DOI : 10.2215/CJN.04760512

M. Noris, J. Caprioli, E. Bresin, C. Mossali, G. Pianetti et al., Relative Role of Genetic Complement Abnormalities in Sporadic and Familial aHUS and Their Impact on Clinical Phenotype, Clinical Journal of the American Society of Nephrology, vol.5, issue.10, pp.1844-59, 2010.
DOI : 10.2215/CJN.02210310

E. Bresin, E. Rurali, J. Caprioli, P. Sanchez-corral, V. Fremeaux-bacchi et al., Combined Complement Gene Mutations in Atypical Hemolytic Uremic Syndrome Influence Clinical Phenotype, Journal of the American Society of Nephrology, vol.24, issue.3, pp.475-86, 2013.
DOI : 10.1681/ASN.2012090884

M. Lemaire, V. Frémeaux-bacchi, F. Schaefer, M. Choi, W. Tang et al., Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome, Nature Genetics, vol.243, issue.5, pp.531-537, 2013.
DOI : 10.1177/22.12.1077
URL : https://hal.archives-ouvertes.fr/hal-01064383

S. Bruneau, M. Néel, L. Roumenina, M. Frimat, L. Laurent et al., Loss of DGK?? induces endothelial cell activation and death independently of complement activation, Blood, vol.125, issue.6, pp.1038-1084, 2014.
DOI : 10.1182/blood-2014-06-579953

S. Rodríguez-de-córdoba, M. Hidalgo, S. Pinto, and A. Tortajada, Genetics of atypical hemolytic uremic syndrome (aHUS), Semin Thromb Hemost, vol.40, pp.422-452, 2014.

F. Sansbury, H. Cordell, C. Bingham, G. Bromilow, A. Nicholls et al., Factors determining penetrance in familial atypical haemolytic uraemic syndrome, Journal of Medical Genetics, vol.8, issue.11, pp.756-64, 2014.
DOI : 10.1136/jmedgenet-2014-102498

M. Frimat, F. Tabarin, J. Dimitrov, C. Poitou, L. Halbwachs-mecarelli et al., Complement activation by heme as a secondary hit for atypical hemolytic uremic syndrome, Blood, vol.122, issue.2, pp.282-92, 2013.
DOI : 10.1182/blood-2013-03-489245

A. Pawluczkowycz, M. Lindorfer, J. Waitumbi, and R. Taylor, Hematin Promotes Complement Alternative Pathway-Mediated Deposition of C3 Activation Fragments on Human Erythrocytes: Potential Implications for the Pathogenesis of Anemia in Malaria, The Journal of Immunology, vol.179, issue.8, pp.19505543-52, 2007.
DOI : 10.4049/jimmunol.179.8.5543

M. Dragon-durey, C. Blanc, M. Marinozzi, R. Van-schaarenburg, and L. Trouw, Autoantibodies against complement components and functional consequences, Molecular Immunology, vol.56, issue.3, pp.213-234, 2013.
DOI : 10.1016/j.molimm.2013.05.009

D. Paixão-cavalcante, M. López-trascasa, L. Skattum, P. Giclas, T. Goodship et al., Sensitive and specific assays for C3 nephritic factors clarify mechanisms underlying complement dysregulation, Kidney International, vol.82, issue.10, pp.1084-92, 2012.
DOI : 10.1038/ki.2012.250

A. Servais, L. Noël, L. Roumenina, L. Quintrec, M. Ngo et al., Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies, Kidney International, vol.82, issue.4, pp.454-64, 2012.
DOI : 10.1038/ki.2012.63

R. Martínez-barricarte, M. Heurich, F. Valdes-cañedo, E. Vazquez-martul, E. Torreira et al., Human C3 mutation reveals a mechanism of dense deposit disease pathogenesis and provides insights into complement activation and regulation, Journal of Clinical Investigation, vol.120, issue.10, pp.3702-1210, 1172.
DOI : 10.1172/JCI43343DS1

Y. Zhang, N. Meyer, K. Wang, C. Nishimura, K. Frees et al., Causes of Alternative Pathway Dysregulation in Dense Deposit Disease, Clinical Journal of the American Society of Nephrology, vol.7, issue.2, pp.265-74, 2012.
DOI : 10.2215/CJN.07900811

Q. Chen, M. Wiesener, H. Eberhardt, A. Hartmann, B. Uzonyi et al., Complement factor H???related hybrid protein deregulates complement in dense deposit disease, Journal of Clinical Investigation, vol.124, issue.1, pp.145-55, 2014.
DOI : 10.1172/JCI71866DS1

E. Goicoechea-de-jorge, J. Caesar, T. Malik, M. Patel, M. Colledge et al., Dimerization of complement factor H-related proteins modulates complement activation in vivo, Proceedings of the National Academy of Sciences, vol.110, issue.12, pp.4685-90, 2013.
DOI : 10.1073/pnas.1219260110

T. Malik, P. Lavin, E. Goicoechea-de-jorge, K. Vernon, K. Rose et al., A Hybrid CFHR3-1 Gene Causes Familial C3 Glomerulopathy, Journal of the American Society of Nephrology, vol.23, issue.7, pp.1155-60, 2012.
DOI : 10.1681/ASN.2012020166

D. Gale, E. De-jorge, H. Cook, R. Martinez-barricarte, A. Hadjisavvas et al., Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis, The Lancet, vol.376, issue.9743, pp.794-801, 2010.
DOI : 10.1016/S0140-6736(10)60670-8

A. Edwards, R. Ritter, K. Abel, A. Manning, C. Panhuysen et al., Complement Factor H Polymorphism and Age-Related Macular Degeneration, Science, vol.308, issue.5720, pp.421-425, 2005.
DOI : 10.1126/science.1110189

G. Hageman, D. Anderson, L. Johnson, L. Hancox, A. Taiber et al., From The Cover: A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration, Proceedings of the National Academy of Sciences, vol.102, issue.20, pp.7227-7259, 2005.
DOI : 10.1073/pnas.0501536102

J. Haines, M. Hauser, S. Schmidt, W. Scott, L. Olson et al., Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration, Science, vol.308, issue.5720, pp.419-440, 2005.
DOI : 10.1126/science.1110359

R. Klein, C. Zeiss, E. Chew, J. Tsai, R. Sackler et al., Complement Factor H Polymorphism in Age-Related Macular Degeneration, Science, vol.308, issue.5720, pp.385-394, 2005.
DOI : 10.1126/science.1109557

L. Lim, P. Mitchell, J. Seddon, F. Holz, and T. Wong, Age-related macular degeneration, The Lancet, vol.379, issue.9827, pp.1728-3810, 2012.
DOI : 10.1016/S0140-6736(12)60282-7

P. Shaw, L. Zhang, M. Zhang, H. Du, L. Zhao et al., Complement factor H genotypes impact risk of age-related macular degeneration by interaction with oxidized phospholipids, Proceedings of the National Academy of Sciences, vol.109, issue.34, pp.13757-62, 2012.
DOI : 10.1073/pnas.1121309109

D. Weismann, K. Hartvigsen, N. Lauer, K. Bennett, H. Scholl et al., Complement factor H binds malondialdehyde epitopes and protects from oxidative stress, Nature, vol.9, issue.7367, pp.76-8110, 1038.
DOI : 10.1038/nature10449

J. Seddon, Y. Yu, E. Miller, R. Reynolds, P. Tan et al., Rare variants in CFI, C3 and C9 are associated with high risk of advanced age-related macular degeneration, Nature Genetics, vol.45, issue.11, pp.1366-70, 2013.
DOI : 10.1086/503876

C. Skerka, Q. Chen, V. Fremeaux-bacchi, and L. Roumenina, Complement factor H related proteins (CFHRs), Molecular Immunology, vol.56, issue.3, pp.170-80, 2013.
DOI : 10.1016/j.molimm.2013.06.001

A. Hughes, N. Orr, H. Esfandiary, M. Diaz-torres, T. Goodship et al., A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration, Nature Genetics, vol.39, issue.10, pp.1173-710, 1038.
DOI : 10.1093/bioinformatics/bth457

L. Fritsche, N. Lauer, A. Hartmann, S. Stippa, C. Keilhauer et al., An imbalance of human complement regulatory proteins CFHR1, CFHR3 and factor H influences risk for age-related macular degeneration (AMD), Human Molecular Genetics, vol.19, issue.23, pp.4694-704, 2010.
DOI : 10.1093/hmg/ddq399

A. Tortajada, H. Yébenes, C. Abarrategui-garrido, J. Anter, J. García-fernández et al., C3 glomerulopathy???associated CFHR1 mutation alters FHR oligomerization and complement regulation, Journal of Clinical Investigation, vol.123, issue.6, pp.2434-2480, 2013.
DOI : 10.1172/JCI68280DS1

M. Cho, H. Vasquez, R. Rupaimoole, S. Pradeep, S. Wu et al., Autocrine Effects of Tumor-Derived Complement, Cell Reports, vol.6, issue.6, pp.1085-95, 2014.
DOI : 10.1016/j.celrep.2014.02.014

L. Corrales, D. Ajona, S. Rafail, J. Lasarte, J. Riezu-boj et al., Anaphylatoxin C5a Creates a Favorable Microenvironment for Lung Cancer Progression, The Journal of Immunology, vol.189, issue.9, pp.4674-83, 1950.
DOI : 10.4049/jimmunol.1201654

S. Vadrevu, N. Chintala, S. Sharma, P. Sharma, C. Cleveland et al., Complement C5a Receptor Facilitates Cancer Metastasis by Altering T-Cell Responses in the Metastatic Niche, Cancer Research, vol.74, issue.13, pp.3454-65, 2014.
DOI : 10.1158/0008-5472.CAN-14-0157

L. Surace, V. Lysenko, A. Fontana, V. Cecconi, H. Janssen et al., Complement Is a Central Mediator of Radiotherapy-Induced Tumor-Specific Immunity and Clinical Response, Immunity, vol.42, issue.4, pp.767-77, 2015.
DOI : 10.1016/j.immuni.2015.03.009

D. Ajona, Z. Castaño, M. Garayoa, E. Zudaire, M. Pajares et al., Expression of Complement Factor H by Lung Cancer Cells: Effects on the Activation of the Alternative Pathway of Complement, Cancer Research, vol.64, issue.17, pp.6310-6318, 2004.
DOI : 10.1158/0008-5472.CAN-03-2328

T. Cui, Y. Chen, T. Knösel, L. Yang, K. Zöller et al., Human complement factor H is a novel diagnostic marker for lung adenocarcinoma, Int J Oncol, vol.39, pp.161-169, 1010.

R. Kinders, T. Jones, R. Root, C. Bruce, H. Murchison et al., Complement factor H or a related protein is a marker for transitional cell cancer of the bladder, Clin Cancer Res, vol.4, pp.2511-2531, 1998.

P. Riihilä, L. Nissinen, R. Kallajoki, M. Grénman, R. Meri et al., Complement Factor H: A Biomarker for Progression of Cutaneous Squamous Cell Carcinoma, Journal of Investigative Dermatology, vol.134, issue.2, pp.498-506, 2014.
DOI : 10.1038/jid.2013.346

P. Santhekadur, D. Rajasekaran, A. Siddiq, R. Gredler, D. Chen et al., The transcription factor LSF: a novel oncogene for hepatocellular carcinoma

N. Amornsiripanitch, S. Hong, M. Campa, M. Frank, E. Gottlin et al., Complement Factor H Autoantibodies Are Associated with Early Stage NSCLC, Clinical Cancer Research, vol.16, issue.12, pp.3226-3257, 2010.
DOI : 10.1158/1078-0432.CCR-10-0321

E. Bonavita, S. Gentile, M. Rubino, V. Maina, R. Papait et al., PTX3 Is an Extrinsic Oncosuppressor Regulating Complement-Dependent Inflammation in Cancer, Cell, vol.160, issue.4, pp.700-714, 2015.
DOI : 10.1016/j.cell.2015.01.004

P. Riihilä, L. Nissinen, M. Farshchian, A. Kivisaari, R. Ala-aho et al., Complement Factor I Promotes Progression of Cutaneous Squamous Cell Carcinoma, Journal of Investigative Dermatology, vol.135, issue.2, pp.579-88, 2015.
DOI : 10.1038/jid.2014.376

P. Arkwright, P. Riley, S. Hughes, H. Alachkar, and R. Wynn, Successful cure of C1q deficiency in human subjects treated with hematopoietic stem cell transplantation, Journal of Allergy and Clinical Immunology, vol.133, issue.1, 2014.
DOI : 10.1016/j.jaci.2013.07.035

H. Longhurst and M. Cicardi, Hereditary angio-oedema, The Lancet, vol.379, issue.9814, pp.474-81, 2012.
DOI : 10.1016/S0140-6736(11)60935-5

P. Mehta, P. Norsworthy, A. Hall, S. Kelly, M. Walport et al., SLE with C1q deficiency treated with fresh frozen plasma: a 10-year experience, Rheumatology, vol.49, issue.4, pp.823-827, 2010.
DOI : 10.1093/rheumatology/kep387

G. Ariceta, N. Besbas, S. Johnson, D. Karpman, D. Landau et al., Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome, Pediatric Nephrology, vol.44, issue.Suppl 3, pp.687-96, 2009.
DOI : 10.1007/s00467-008-0964-1

S. Johnson, J. Stojanovic, G. Ariceta, M. Bitzan, N. Besbas et al., An audit analysis of a guideline for the investigation and initial therapy of diarrhea negative (atypical) hemolytic uremic syndrome, Pediatric Nephrology, vol.50, issue.10, pp.1967-78, 2014.
DOI : 10.1007/s00467-014-2817-4

J. Zuber, F. Fakhouri, L. Roumenina, C. Loirat, V. Frémeaux-bacchi et al., Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies, Nature Reviews Nephrology, vol.26, issue.11, pp.643-57, 2012.
DOI : 10.1038/nrneph.2012.214

P. Hillmen, N. Young, J. Schubert, R. Brodsky, G. Socié et al., The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria, New England Journal of Medicine, vol.355, issue.12, pp.1233-1276, 2006.
DOI : 10.1056/NEJMoa061648
URL : https://hal.archives-ouvertes.fr/hal-00599451

C. Legendre, C. Licht, and C. Loirat, Eculizumab in atypical hemolytic-uremic syndrome, N Engl J Med, vol.369, pp.1379-80, 2013.

B. Nilsson, R. Larsson, J. Hong, G. Elgue, K. Ekdahl et al., Compstatin inhibits complement and cellular activation in whole blood in two models of extracorporeal circulation, Molecular Immunology, vol.35, issue.6-7, pp.1661-1668, 1998.
DOI : 10.1016/S0161-5890(98)90693-9

A. Risitano, D. Ricklin, Y. Huang, E. Reis, H. Chen et al., Peptide inhibitors of C3 activation as a novel strategy of complement inhibition for the treatment of paroxysmal nocturnal hemoglobinuria, Blood, vol.123, issue.13, pp.2094-101, 2014.
DOI : 10.1182/blood-2013-11-536573

Y. Zhang, C. Nester, D. Holanda, H. Marsh, R. Hammond et al., Soluble CR1 Therapy Improves Complement Regulation in C3 Glomerulopathy, Journal of the American Society of Nephrology, vol.24, issue.11, pp.1820-1829, 2013.
DOI : 10.1681/ASN.2013010045